Literature DB >> 34859887

Colonoscopy utilization and outcomes in older adults: Data from the New Hampshire Colonoscopy Registry.

Audrey H Calderwood1,2,3, Tor D Tosteson2,4, Louise C Walter5,6, Peiying Hua4, Tracy Onega7.   

Abstract

BACKGROUND: Colonoscopy is frequently performed in older adults, yet data on current use, and clinical outcomes of and follow-up recommendations after colonoscopy in older adults are lacking.
METHODS: This was an observational study using the New Hampshire Colonoscopy Registry of adults age ≥65 years undergoing colonoscopy for screening, surveillance of prior polyps, or evaluation of symptoms. The main outcomes were clinical findings of polyps and colorectal cancer and recommendations for future colonoscopy by age.
RESULTS: Between 2009 and 2019, there were 42,611 colonoscopies, of which 17,527 (41%) were screening, 19,025 (45%) surveillance, and 6059 (14%) for the evaluation of symptoms. Mean age was 71.1 years (SD 5.0), and 49.3% were male. The finding of colorectal cancer was rare (0.71%), with the highest incidence among diagnostic examinations (2.4%). The incidence of advanced polyps increased with patient age from 65-69 to ≥85 years for screening (7.1% to 13.6%; p = 0.05) and surveillance (9.4% to 12.0%; p < 0.001). Recommendations for future colonoscopy decreased with age and varied by findings at current colonoscopy. In patients without any significant findings, 85% aged 70-74 years, 61.9% aged 75-79 years, 39.1% aged 80-84 years, and 27.4% aged ≥85 years (p < 0.001) were told to continue colonoscopy. Among patients with advanced polyps, 97.2% aged 70-74 years, 89.6% aged 75-79 years, 78.4% aged 80-84 years, and 66.7% aged ≥85 years were told to continue colonoscopy (p < 0.001).
CONCLUSIONS: Within this comprehensive statewide registry, clinical findings during colonoscopy varied by indication and increased with age. Overall rates of finding advanced polyps and colorectal cancer are low. Older adults are frequently recommended to continue colonoscopy despite advanced age and insignificant clinical findings on current examination. These data inform the potential benefits of ongoing colonoscopy, which must be weighed with the low but known potential immediate and long-term harms of colonoscopy, including cost, psychological distress, and long lag time to benefit exceeding life expectancy.
© 2021 The American Geriatrics Society.

Entities:  

Keywords:  age; colorectal cancer screening; polyp surveillance; recommendations

Mesh:

Year:  2021        PMID: 34859887      PMCID: PMC8904292          DOI: 10.1111/jgs.17560

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  32 in total

Review 1.  Adverse events in older patients undergoing colonoscopy: a systematic review and meta-analysis.

Authors:  Lukejohn W Day; Annette Kwon; John M Inadomi; Louise C Walter; Ma Somsouk
Journal:  Gastrointest Endosc       Date:  2011-10       Impact factor: 9.427

2.  Matching colonoscopy and pathology data in population-based registries: development of a novel algorithm and the initial experience of the New Hampshire Colonoscopy Registry.

Authors:  Mary Ann Greene; Lynn F Butterly; Martha Goodrich; Tracy Onega; John A Baron; David A Lieberman; Allen J Dietrich; Amitabh Srivastava
Journal:  Gastrointest Endosc       Date:  2011-06-12       Impact factor: 9.427

3.  ASGE review of adverse events in colonoscopy.

Authors:  Shivangi T Kothari; Robert J Huang; Aasma Shaukat; Deepak Agrawal; James L Buxbaum; Syed M Abbas Fehmi; Douglas S Fishman; Suryakanth R Gurudu; Mouen A Khashab; Laith H Jamil; Terry L Jue; Joanna K Law; Jeffrey K Lee; Mariam Naveed; Bashar J Qumseya; Mandeep S Sawhney; Nirav Thosani; Julie Yang; John M DeWitt; Sachin Wani
Journal:  Gastrointest Endosc       Date:  2019-09-25       Impact factor: 9.427

4.  Impact of fair bowel preparation quality on adenoma and serrated polyp detection: data from the New Hampshire colonoscopy registry by using a standardized preparation-quality rating.

Authors:  Joseph C Anderson; Lynn F Butterly; Christina M Robinson; Martha Goodrich; Julia E Weiss
Journal:  Gastrointest Endosc       Date:  2014-05-10       Impact factor: 9.427

5.  Predictors of colorectal cancer screening variation among primary-care providers and clinics.

Authors:  Jennifer M Weiss; Maureen A Smith; Perry J Pickhardt; Sally A Kraft; Grace E Flood; David H Kim; Elizabeth Strutz; Patrick R Pfau
Journal:  Am J Gastroenterol       Date:  2013-05-14       Impact factor: 10.864

6.  Primary Care Clinician Decision-Making Around Surveillance Colonoscopies in Older Adults with Prior Adenomas.

Authors:  Nancy L Schoenborn; Cynthia M Boyd; Jacqueline Massare; Reuben Park; Youngjee Choi; Craig E Pollack
Journal:  J Am Board Fam Med       Date:  2020 Sep-Oct       Impact factor: 2.657

7.  Serious complications within 30 days of screening and surveillance colonoscopy are uncommon.

Authors:  Cynthia W Ko; Stacy Riffle; Leann Michaels; Cynthia Morris; Jennifer Holub; Jean A Shapiro; Marcia A Ciol; Michael B Kimmey; Laura C Seeff; David Lieberman
Journal:  Clin Gastroenterol Hepatol       Date:  2009-10-20       Impact factor: 11.382

8.  Differences in detection rates of adenomas and serrated polyps in screening versus surveillance colonoscopies, based on the new hampshire colonoscopy registry.

Authors:  Joseph C Anderson; Lynn F Butterly; Martha Goodrich; Christina M Robinson; Julia E Weiss
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-06       Impact factor: 11.382

9.  Smoking and Other Risk Factors in Individuals With Synchronous Conventional High-Risk Adenomas and Clinically Significant Serrated Polyps.

Authors:  Joseph C Anderson; Audrey H Calderwood; Brock C Christensen; Christina M Robinson; Christopher I Amos; Lynn Butterly
Journal:  Am J Gastroenterol       Date:  2018-11-01       Impact factor: 10.864

10.  Adverse events after outpatient colonoscopy in the Medicare population.

Authors:  Joan L Warren; Carrie N Klabunde; Angela B Mariotto; Angela Meekins; Marie Topor; Martin L Brown; David F Ransohoff
Journal:  Ann Intern Med       Date:  2009-06-16       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.